Skip to content

Clinical trials

Observational Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Observational Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20032
20045
20054
20063
20071
20082
20097
201012
20111
20124
20135
201412
20156
20165
20176
20186
20199
20209
202113
20229
20239
20248
202512
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Recruiting25
Unknown status24
Not yet recruiting17
Active, not recruiting7
Terminated5
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline17
Boehringer Ingelheim11
Boston Scientific Corporation5
Seoul National University Hospital5
Necmettin Erbakan University3
University of Florence3
University of Kansas Medical Center3
Ain Shams University2
Ankara City Hospital Bilkent2
Assistance Publique - Hôpitaux de Paris2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia178
Prostatic Neoplasms32
Lower Urinary Tract Symptoms29
Urinary Bladder Neck Obstruction6
Urinary Incontinence6
Urinary Retention6
Erectile Dysfunction4
Kidney Calculi4
Urinary Bladder Neoplasms4
Urinary Bladder, Overactive3

Trials

Showing 76 to 100 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.